Australia Peptide Microarray Market Size & Outlook
Related Markets
Australia peptide microarray market highlights
- The Australia peptide microarray market generated a revenue of USD 11.3 million in 2023 and is expected to reach USD 16.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating type in 2023.
- Services is the most lucrative type segment registering the fastest growth during the forecast period.
Peptide microarray market data book summary
| Market revenue in 2023 | USD 11.3 million |
| Market revenue in 2030 | USD 16.3 million |
| Growth rate | 5.3% (CAGR from 2024 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | PEPperPRINT, RayBiotech, Creative-Biolabs, Aurora Innovation Inc Class A, Spectrum Solutions, Bio-Rad Laboratories Inc, BioNTech SE ADR, Merck KGaA, Innopsys |
Other key industry trends
- In terms of revenue, Australia accounted for 1.4% of the global peptide microarray market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan peptide microarray market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 24.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Microarray Market Scope
Peptide Microarray Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Innopsys | View profile | - | Carbonne, Midi-Pyrenees, France, Europe | https://www.innopsys.com |
| Spectrum Solutions | View profile | 51-100 | Utah, Tennessee, United States, North America | http://www.spectrum-solutions.us |
| PEPperPRINT | View profile | 11-50 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.pepperprint.com |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | https://www.creative-biolabs.com |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| BioNTech SE ADR | View profile | 6133 | An der Goldgrube 12, Mainz, RP, Germany, D-55131 | https://www.biontech.de |
| Aurora Innovation Inc Class A | View profile | 1800 | 1654 Smallman Street, Pittsburgh, PA, United States, 15222 | https://www.aurora.tech |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Australia peptide microarray market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide microarray market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 57.52% in 2023. Horizon Databook has segmented the Australia peptide microarray market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia peptide microarray market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia peptide microarray market databook
-
Our clientele includes a mix of peptide microarray market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia peptide microarray market, including forecasts for subscribers. This country databook contains high-level insights into Australia peptide microarray market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia peptide microarray market report size, by type, 2018-2030 (US$M)
Australia Peptide Microarray Market Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
